WEBINAR: New Paradigms in the Management and Treatment of Diabetic Macular Edema (Part 3)
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
NoneSupported through an educational grant by Alimera Sciences. Learning Objectives
Upon completion of this activity, the participant should be able to: •Describe the current epidemiology of diabetic macular edema and diabetic retinopathy •Educate patients on the ophthalmic implications of systemic diabetes management •Assess clinical studies involving new approaches to treat DME •Use expert case examples to differentiate between clinical study dosing protocols and alternative dosing schedules •Evaluate treatment options and develop a treatment regimen that can reduce patient burden and practice capacity •Explain the early warning signs of elevated IOP •Identify effective management strategies for patients requiring intervention Accreditation
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education and Retina Today.
Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Grantor Statement
This continuing medical education activity is supported through an unrestricted educational grant from Alimera Sciences.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Alexander Eaton, MD Retina Health Center Fort Meyers, Florida
Szilard Kiss, MD Weill Cornell Medicine New York, New York
The following faculty members have the following financial relationships with commercial interests: Alexander Eaton, MD, has had a financial agreement or affiliation during the past year with the following: Speaker’s Bureau: Alimera Sciences. Grant/Research Support: Alimera Sciences; Allergan; Genentech and Regeneron Pharmaceuticals. Stock Shareholder: Alimera Sciences and Regeneron Pharmaceuticals. Szilárd Kiss, MD, has had a financial agreement or affiliation during the past year with the following: Retained Consultant: Alimera Science; Allergan; Genentech; Regeneron Pharmaceuticals. Speakers Bureau: Alimera Science; Allergan; Genentech; Regeneron Pharmaceuticals.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!